Allay Therapeutics

Home • Allay Therapeutics

San Jose, United States · Founded 2015 · $133.5M raised

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$133.5M
Last Round
$57.5M Series DJun 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Allay Therapeutics is a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management. Its lead program, ATX-101, uses extended-release local anesthetic formulations designed to provide long-lasting pain relief while reducing dependence on opioids. The company aims to expand the surgical pain management toolkit with safer, longer-lasting, and more tailored solutions.

Summary

Allay Therapeutics is a Biotech company based in San Jose, United States, founded in 2015. It has raised $133.5M in total across 3 rounds, most recently a $57.5M Series D round in Jun 2025. Investors include Arboretum Ventures, Lightstone Ventures and ClavystBio.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DJun 2025
$57.5M

Sign up to see all 3 events

Funding: Series C through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allay Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/allay-therapeutics"><img src="https://indexed.vc/api/badge/company/allay-therapeutics" alt="Allay Therapeutics on Indexed.vc" width="260" height="76" /></a>